By Herman Tiu Laurel (Part 1: mRNA’s yet Unchartered Waters)
It took me some time to ascribe as “imperialism” the US behavior on its vaccine promotion efforts, but after reviewing the course of events since the start of the Covid-19 crisis I found this as an inescapable fact – the US has tried to impose on the world its new vaccine development, its parameters for defining “efficacy” and its pernicious propaganda efforts at putting down other countries’ vaccine projects.
US Vaccine Imperialism Backfires
Tag: mRNA
Chinese health experts call to suspend Pfizer’s mRNA vaccine for elderly after Norwegian deaths
Mexican doctor hospitalised after receiving Pfizer COVID-19 vaccine
RFK, Jr. Urges FDA to Slow Down COVID Vaccine Approval Process
RFK, Jr. Urges FDA to Slow Down COVID Vaccine Approval Process
In a letter to Peter Marks, director of the Center for Biologics Evaluation and Research, Robert F. Kennedy, Jr. asks the U.S. Food and Drug Administration to take a cautious approach in approving COVID-19 vaccines that have been developed at “warp speed.”
EU criticises ‘hasty’ UK approval of COVID-19 vaccine
EU criticises ‘hasty’ UK approval of COVID-19 vaccine
European Medicines Agency says its approval process is more appropriate, as German politician calls UK move ‘problematic’.
Emergency approval of coronavirus vaccines is not guaranteed, FDA commissioner says
Emergency approval of coronavirus vaccines is not guaranteed, FDA commissioner says
Career scientists at the FDA are reviewing raw data from the Pfizer and Moderna trials for the first time, investigating any adverse events or side effects that transpired over the course of the trials, different levels of effectiveness among populations and age groups, and whether individuals who were already infected by the coronavirus might have had any unexpected reactions to the vaccine doses.
Hahn said they will also be looking for evidence that the vaccines lead to increased respiratory infections – a concern with vaccines produced for other coronaviruses, such as SARS and MERS – and whether the use of a relatively new method of vaccine development, known as messenger RNA technology, poses any significant risks.